Valuation: Photocure ASA

Market Cap 1.42B 151M 131M 123M 113M 210M 14.42B 211M 1.48B 570M 7.35B 565M 553M 23.58B P/E 2026 *
18.7x
P/E 2027 * 67.7x
Enterprise Value 1.25B 133M 116M 109M 99.21M 185M 12.71B 186M 1.3B 503M 6.48B 498M 487M 20.78B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.9x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+2.13%
1 week+1.73%
Current month-3.12%
1 month-2.40%
3 months-12.00%
6 months-15.65%
Current year-26.05%
1 week 50.6
Extreme 50.6
53.1
1 month 50.6
Extreme 50.6
56.8
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 46.25
Extreme 46.25
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/25 BuyCompany 11,355 0.0419%
4/2/25 BuyCompany 8,997 0.0332%
3/31/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%+1.73%-10.96%-13.16% 148M
+1.04%+4.41%+54.91%+104.50% 1,028B
-0.19%+1.46%+52.94%+65.41% 651B
+0.20%+2.86%+18.88%+72.18% 466B
+2.24%+5.98%+37.61%+42.44% 346B
+0.90%+3.66%+18.79%+25.03% 266B
+0.48%+7.28%+11.11%+14.70% 259B
+1.95%+4.19%+37.75%+44.83% 208B
-7.65%-5.95%-33.09%-60.76% 191B
+0.30%+4.76%+31.97%+98.58% 186B
Average +0.07%+2.89%+21.99%+39.37% 360.19B
Weighted average by Cap. +0.10%+3.09%+35.56%+62.43%

Financials

2026 *2027 *
Net sales 658M 69.73M 60.82M 57.2M 52.16M 97.17M 6.68B 97.93M 685M 264M 3.4B 262M 256M 10.92B 666M 70.58M 61.56M 57.9M 52.79M 98.35M 6.76B 99.12M 693M 267M 3.45B 265M 259M 11.06B
Net income 76.33M 8.09M 7.05M 6.63M 6.05M 11.27M 775M 11.36M 79.39M 30.64M 395M 30.37M 29.69M 1.27B 21M 2.22M 1.94M 1.82M 1.66M 3.1M 213M 3.12M 21.84M 8.43M 109M 8.36M 8.17M 348M
Net Debt -169M -17.9M -15.61M -14.68M -13.39M -24.94M -1.72B -25.14M -176M -67.83M -874M -67.24M -65.74M -2.8B -157M -16.63M -14.51M -13.64M -12.44M -23.17M -1.59B -23.35M -163M -63.02M -812M -62.47M -61.07M -2.6B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-09-21 NOK 52.80 +2.13% 37,508
26-09-18 NOK 51.70 -0.58% 29,298
26-09-17 NOK 52.00 +0.78% 19,444
26-09-16 NOK 51.60 +0.98% 60,082
26-09-15 NOK 51.10 -0.78% 31,977
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
52.80NOK
Average target price
79.67NOK
Spread / Average Target
+50.88%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!